Correlation Between Tidehold Development and Sinphar Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tidehold Development and Sinphar Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tidehold Development and Sinphar Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tidehold Development Co and Sinphar Pharmaceutical Co, you can compare the effects of market volatilities on Tidehold Development and Sinphar Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tidehold Development with a short position of Sinphar Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tidehold Development and Sinphar Pharmaceutical.

Diversification Opportunities for Tidehold Development and Sinphar Pharmaceutical

0.93
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Tidehold and Sinphar is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Tidehold Development Co and Sinphar Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinphar Pharmaceutical and Tidehold Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tidehold Development Co are associated (or correlated) with Sinphar Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinphar Pharmaceutical has no effect on the direction of Tidehold Development i.e., Tidehold Development and Sinphar Pharmaceutical go up and down completely randomly.

Pair Corralation between Tidehold Development and Sinphar Pharmaceutical

Assuming the 90 days trading horizon Tidehold Development Co is expected to generate 1.75 times more return on investment than Sinphar Pharmaceutical. However, Tidehold Development is 1.75 times more volatile than Sinphar Pharmaceutical Co. It trades about 0.05 of its potential returns per unit of risk. Sinphar Pharmaceutical Co is currently generating about -0.01 per unit of risk. If you would invest  1,235  in Tidehold Development Co on August 29, 2024 and sell it today you would earn a total of  525.00  from holding Tidehold Development Co or generate 42.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Tidehold Development Co  vs.  Sinphar Pharmaceutical Co

 Performance 
       Timeline  
Tidehold Development 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tidehold Development Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Sinphar Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sinphar Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Tidehold Development and Sinphar Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tidehold Development and Sinphar Pharmaceutical

The main advantage of trading using opposite Tidehold Development and Sinphar Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tidehold Development position performs unexpectedly, Sinphar Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinphar Pharmaceutical will offset losses from the drop in Sinphar Pharmaceutical's long position.
The idea behind Tidehold Development Co and Sinphar Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules